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Background: The management of acquired benign tracheoesophageal fistula (TEF)
and bronchogastric stump fistula (BGSF) is a challenge. This study aimed to assess the
“double-patch” technique with or without esophageal mucosa in treating nonmalignant
TEF and BGSF.
Materials and methods:We established a dog model with TEF by incising the esophageal and
tracheal membranes and suturing them together. The dogs were divided into three groups
(n ¼ 12 per group). Groups A and B received a double-patch 7 d later. The esophageal
mucosa of the patches was cauterized in the group A dogs, kept intact in group B dogs, and
group C dogs did not receive surgical intervention. Tissue healing was measured using
hydroxyproline levels.
Results:Morphologic and histopathologic changes of the esophagus were assessed by gross
observation of the specimens, hematoxylin and eosin staining, tracheal stenosis index, and
hydroxyproline levels. On day 56 after surgery, group A showed a tracheal stenosis index
comparable with that of group C (0.140  0.009 versus 0.138  0.014, P ¼ 1.00), whereas
group B showed a higher stenosis index (0.170  0.007) than group C (P ¼ 0.029). The
hydroxyproline levels were higher in group A than in B and C on day 7 (P ¼ 0.029), and this
difference was statistically significant on days 14 and 56 (all P < 0.001).
Conclusions: The use of an esophageal “double-patch” technique without mucosa showed
faster and more stable recovery than patches with mucosa in the repair of acquired
nonmalignant complicated TEF and BGSF.
ª 2016 The Author(s). Published by Elsevier Inc. This is an open access article under the CC
BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).acic Surgery, Tangdu Hospital, The Fourth Military Medical University, Xi’an 710038, China.
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2 j o u r n a l o f s u r g i c a l r e s e a r c h  ma r c h 2 0 1 7 ( 2 0 9 ) 1e7Introduction pedicled muscle flap to resist the high airway pressure is aAcquired nonmalignant fistula between the airway and upper
gastrointestinal tract is a rare but challenging clinical
problem.1 Patients with this condition have little chance of
self-recovery. Abnormal communication between the airway
and upper gastrointestinal tract leads to continuous
contamination of the tracheobronchial tree and repeated
respiratory infections. In the absence of timely intervention,
patients may die from respiratory failure or malnutrition,
usually within 3-4 mo.2,3 The etiology of the fistula includes
complications of mechanical ventilation, indwelling tracheal
or esophageal stents, complications from prior tracheal or
esophageal surgery, granulomatous mediastinal infections,
trauma, iatrogenic injuries, and caustic ingestion.1 Acquired
nonmalignant complicated tracheoesophageal fistula (TEF)
and bronchogastric stumpfistula (BGSF) are characterized by a
large fistula (1 cm), severe inflammation, high rate of post-
operative death and recurrence, difficult stent placement,
need for segmental tracheal or bronchial resection, and
primary anastomosis of esophageal and tracheal defects that
cannot be surgically repaired.4,5
Several studies have proposed a number of different
approaches to treat acquired nonmalignant TEF and BGSF.6-9
Currently available treatments include minimally invasive
procedures and surgeries. Previous studies have shown
varying levels of success in the use of minimally invasive
procedures in patients with early detection, small fistula
(<1 cm), and mild local infection.10-16 Although minimally
invasive procedures are useful in handling simple and small
traumas, they are associated with increased postoperative
complications and have a high recurrence rate.10,17,18 Some
surgeons suggest treating patients with complicated fistula
(1 cm), severe local infection, and tissue edema using
respiratory tract resection combined with end-to-end
anastomosis. However, this method has its own limitations:
the procedure is complicated, it is associated with a higher
number of complications as well as a wide range of
complications, and a high mortality rate. In addition, the
length of the respiratory tract that can be removed is limited,
adding to the disadvantages of this approach. Other
alternatives to the complex surgical procedure of respiratory
tract resection include the use of autologous flaps,
pericardium, allogeneic pericardium, and other materials
(such as the AlloDerm patch) to repair the fistula, although
these methods are associated with insufficient blood
supply, limited material, allograft rejection, high recurrence
rate, and the need for separating surrounding tissues from
the fistula.19,20 Previous studies have reported that a
neomembranous airway with a single-layer posterior
esophageal wall or with a pedicled muscle flap can
successfully close large TEFs.21-23 There are several
advantages to this approach: the flap can be obtained locally,
no allograft rejection occurs, there is no need to separate the
surrounding tissues from the fistula, no removal of the
respiratory tract, and the muscle flap can resist the high
airway pressure. However, a single-layer esophageal flap may
not resist the high pressure in the airway, potentially leading
to recurrence of fistula and tracheal stenosis,21 and using acomplicated procedure, as the availability of material is
limited, and the blood supply cannot be guaranteed.
In the present study, we report the use of a novel
“double-patch” technique for repairing tracheal defects. This
technique uses a double-layered approach to close the defect
in the esophageal walls of the trachea or bronchus.4 Due to the
problems of cyst formation due to secreting cells in the
esophageal mucosa, this study aimed to compare the
outcomes using a patch with and without esophageal mucosa
for fistula closure in an animal model.Materials and methods
Animals and anesthesia
All animal experiments were approved by the Ethics
Committee of the Fourth Military Medical University (China)
and performed in accordance with the Animal Research:
Reporting In Vivo Experiments guidelines. All the animals had
free access to food and water.
A total of 36 healthy adult beagles (average weight:
11.8  2.6 kg, irrespective of gender) were obtained from the
Animal Experiment Center of the Fourth Military Medical
University and divided into three groups (n ¼ 12 each): an
experimental group (group A), a control group (group B), and a
blank group (group C). The esophageal mucosa of the patches
was cauterized in the group A dogs, kept intact in group B
dogs, and dogs of group C did not receive any surgical
intervention.
All the surgical procedures and euthanasiawere performed
under general anesthesia using intramuscular injection of
25-mg/kg ketamine (Ketalar; Parke-Davis & Co, Detroit, MI)
and 10-mg/kg xylazine (Rompun; Bayer Ag, Leverkusen,
Germany), and an intravenous infusion of 0.9%-NaCl
at 30 mL/(kg$h)1. The surgical site was shaved and
treated with povidone iodine for disinfection of the skin.
Pulmonary ventilation after orotracheal intubation was
performed using the Mapleson D system with an oxygen flow
of 70 mL/kg.24,25Establishment of the model
In the groups A and B dogs, a 10-cm incision was made on the
left side of the neck, 1.5 cm away from the longitudinal
midline. The esophagus and tracheawere fully exposed, and a
2.5-cm longitudinal incision was made on the anterior wall of
the esophagus and the tracheal membrane. Using 3-0 absorb-
able sutures, an interrupted suture was made on the edge of
the incision of the esophageal and tracheal membrane. All
models were created successfully. At the same time, a feeding
gastrostomywas performed, and oral food intakewas stopped
in groups A and B during the postoperative period. The fistulas
were examined after 7 d using a bronchoscope by injecting
methylene blue into the esophageal lumen (Fig. 1). The dogs in
groups Cwere handled in exactly the sameway as in the other
two groups, but they did not undergo any surgery.
Fig. 1 e (A and B) Fistula models were examined by bronchoscopy after 7 d. (F[ fistula; B[ tracheal lumen). (Color version
of figure is available online.)
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After 7 d of establishing the model, a “double-patch” tech-
niquewas used for groupsA and B. The esophageal lumenwas
cutoff from the proximal and distal edges of the fistula by
1 cm. A longitudinal incision was made on the posterior
esophageal wall to form two esophageal patches, a long one
and a short one, on both sides of the fistula. The esophageal
mucosa of the patches was cauterized in group A and kept
intact in group B. The short patch was sutured to the left edge
of the fistula with interrupted full-thickness suture, and the
fistula was completely closed. This short patch was then
covered with a long patch. The exclusion was operated on theFig. 2 e The “double-patch” technique was performed in groups
one and a short one, on both sides of the fistula. The fistula wa
covered by the long patch. Esophageal stumps were excluded in
examined using a bronchoscope. (B [ trachea lumen; S [ shor
D [ distal stump of the esophagus; T [ proximal stump of the
online.)proximal and distal stump of the esophagus in the antero-
lateral region of the right side of the neck (Fig. 2A). The
repaired fistula was examined with a bronchoscope on
postoperative day 7 (Fig. 2B).Postoperative care
For the first 48 h after surgery, the animals received analgesia
with intramuscular promazine hydrochloride (2 mL) and
dipyrone (2 mL) twice a day. A single dose of benzylpenicillin
procaine (500,000 UI/kg) was administrated immediately after
induction of anesthesia.A and B. (A) Two esophageal patches were formed, a long
s covered by the short patch. The short patch was then
the anterolateral part of the right neck. (B) The fistula was
t patch; L [ long patch; C [ endotracheal intubation;
esophagus; P [ patch). (Color version of figure is available
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On postoperative days 7, 14, and 56, four dogs from each group
were euthanized by intravenous injection of KCl to induce
cardiac arrest. The survival of experimental animals was
observed before euthanasia. Tissues were harvested for the
tests described in the following section.
Tracheal stenosis index
After harvesting the trachea from the animals, it was opened
longitudinally. The maximum wall thickness of the
patches was measured using a pachymeter. The minimum
intraluminal perimeter of the trachea was assessed in the
fistulae of groups A and B. The wall thickness of the tracheal
membrane and intraluminal perimeter of the trachea were
also assessed in group C. The intraluminal diameter was
calculated as the intraluminal perimeter/p. The tracheal
stenosis index (wall thickness/intraluminal diameter) was
calculated using the same formula as that for esophageal
stenosis.25,26
Histology
Tissue sections of the patch and normal esophageal tissues
were immediately dissected using a scalpel into approxi-
mately 5  5 mm2 pieces and incubated in 10% formalin for
12-24 h. Hematoxylin and eosin (HE) staining was carried out
according to standard protocols.27 Images of each tissue
section were captured with a Zeiss Axiovert 40 CFL
inverted digital light microscope (Carl Zeiss AG, Jena,
Germany). The microscope was equipped with an InfinityX-
32C, 32-megapixel CCD digital video camera (Lumenera
Corporation, Ottawa, Canada).
Hydroxyproline assay
Tissue healing relies on collagen synthesis and deposition.28
As hydroxyproline constitutes 13.4% of collagen, tissue
healing can be determined by measuring the hydroxyproline
levels in tissue. Therefore, we evaluated the hydroxyproline
levels of the patch using a hydroxyproline assay kit (Hypro-
nosticon, Organon, Holland). The esophageal segment of
normal esophageal tissues and patches were kept at 70C
until the assay. Samples were weighed and homogenized in
serum physiological solution (1/10, w/v) using a tissue grinder.
Tissue homogenates were centrifuged at 3000 g for 15 min,
and the supernatantswere hydrolyzed by adding hydrochloric
acid (37%) at 100C for 16-18 h. Amino acids were oxidized to
form pyrrole derivatives, whichwere developedwith Ehrlich’s
reagent and quantitatively determined at 560 nm using a
spectrophotometer (Bio-Rad, Hercules, CA). All the solutions
were used from the hydroxyproline assay kit (Hypronosticon),
and the results were presented as mg/g wet tissue.24
Statistical analysis
Statistical analyses were performed using SPSS 18.0 (IBM,
Armonk, NY). The stenosis index and hydroxyproline levels
are presented as the mean  standard deviation. Statisticalanalyses were performed using the ManneWhitney U test or
KruskaleWallis H test, as appropriate. A P value of <0.05 was
considered statistically significant.Results
Healing of the patches
As shown in Figure 3A and B, the fistula models were
successfully established with stable outcomes, as confirmed
by HE staining and gross examination of the patches. All dogs
from groups A and B survived until euthanasia. The patches
from groups A and B received more blood flow volume than
the esophagus in group C (Fig. 3A and B).
In group A, the patch layers were well fused together, and
there was an absence of glands in patches and there was no
cyst formation (Fig. 3C and D). In group B, cysts were formed
between the patch layers; this could be attributed to the
presence of more glands in the patches used for group B
(Fig. 3E and F).Tracheal stenosis index
The tracheal stenosis indices of groups A, B, and C were
0.149 0.009, 0.147 0.010, and 0.137 0.010 on postoperative
day 7, respectively; 0.150  0.008, 0.150  0.017, and
0.135  0.013 on postoperative day 14, respectively; and
0.140 0.009, 0.170 0.007, and 0.138 0.014 on postoperative
day 56, respectively (Fig. 4).
No tracheal stenosis occurred in group A on postoperative
days 7, 14, and 56 (compared with group C, all P > 0.05). The
stenosis index was significantly higher in group B than that in
group C on postoperative day 56 (P ¼ 0.029; Fig. 4).
Hydroxyproline levels
The hydroxyproline levels of groups A, B, and C were
488.0  13.3, 421.5  25.0, and 414.0  20.9 mg/g on
postoperative day 7, respectively; 632.3  21.0, 578.8  14.4,
and 415.0  19.8 mg/g on postoperative day 14, respectively;
and 763.8  17.8, 685.8  12.3, and 417.2  20.0 mg/g on
postoperative day 56, respectively (Fig. 5).
The hydroxyproline levels gradually increased in both
groups A and B, whereas the hydroxyproline levels of the
esophageal patches showed significantly earlier and higher
increases in group A than in groups B and C (Fig. 5).Discussion
In this study, we aimed to investigate the morphological and
pathophysiological changes of double patches with or without
mucosa for repairing fistulae in an animal model of TEF.
Results showed that the double patches in groups A and B
received adequate blood supply. The use of patches
containingmucosa in group B animals led to the occurrence of
cysts and tracheal stenosis after surgery. Finally, cauterizing
the esophageal mucosa of the patches in group A may have
Fig. 3 e Blood supply and healing of the patches were visualized by HE staining and gross examination. (A) The submucosal
vessels of the patches were significantly higher in groups A and B on postoperative day 56 (magnification: 3 50; arrow,
vessel). (B) Normal esophageal tissues from group C (magnification: 3 20). (C) Absence of submucosal glands on
postoperative day 56 in group A (magnification: 3 100). (D) The two layers of the patches were well fused, and there
was cicatricial tissue between the long and short patches in group A (magnification: 3 20, S[ short patch; L[ long patch;
C [ cicatricial tissue). (E) Presence of an increased number of submucosal glands on postoperative day 56 in group B
(magnification: 3 100; arrow, submucosal gland). (F) The two patch layers were poorly fused with cyst formation
(B [ trachea; P [ patch). (Color version of figure is available online.)
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of patches, without significant cyst and tracheal stenosis.
Esophageal mucosal and submucosal glands can secrete
large amounts of mucoproteins to protect the mucosa from
hydrogen ions and pepsin.29 In this study, the esophageal
mucosa of group A was cauterized to inhibit mucoprotein
secretion. In contrast, the esophageal mucosa of group B was
conserved. Consequently, hyperplasia of the mucosal gland
and secretion of excessmucoprotein led to fluid accumulation
between the two patches in group B animals. The fluid smear
did not show pus, which excluded the possibility of empyema
resulting from infection. The large amount of cyst fluid
accumulated between the two layers may compress the
airway, and obvious stenosis of the airway was observed on
postoperative day 56 in group B. However, stenosis was not
observed in group A; when no cyst formed, there was no
tracheal stenosis identified. Therefore, these results suggest
that esophageal mucous glands should be completely
removed when performing the “double-patch” technique for
TEF and BGSF.
The extracellular matrix plays a role in tissue repair and
regulation of growth factors involved in healing.30 Tissue
healing relies on the synthesis and deposition of collagen,which is the main component of extracellular matrix.
Hydroxyproline is a unique component of collagen and
accounts for 13.4% of collagen.28 Therefore, the progress of
healing can be determined by measuring the hydroxyproline
levels in tissues. In this study, we cauterized the mucosa of
the esophageal patches in group A, which resulted in local
traumatic adhesion, which might have been conducive to the
synthesis and deposition of collagen and healing of the scars.
The mucosa of the esophageal patches in group B were not
cauterized and were therefore more or less intact; however,
the surgery itself may have caused slight impairment in the
tissue, although this impairment would be less severe in
group B than in group A. Together, the aforementioned
reasons may explain why patches of groups A and B had
higher postoperative hydroxyproline levels than patches of
group C. Moreover, the postoperative hydroxyproline levels
increased earlier and were more clinical significative in group
A than in group B.
Several researchers studying the esophagus tend to use
rats as the experimental animal. However, thus far, no
standard benign TEF/BGSFmodel has yet been reported. In the
present study, we chose to use dogs for a number of reasons.
First, surgery in the neck in dogs is scarcely influenced by
Fig. 4 e The stenosis indices of groups A, B, and C. The
stenosis indices did not significantly differ among the
three groups on postoperative days 7 and 14 (ANOVA
P [ 0.228, P [ 0.201, respectively), but was significantly
higher in group B than in group C on postoperative day 56.
There was no change in the stenosis index in group C
during the study (P [ 0.787). ANOVA [ analysis of
variance.
Fig. 6 e Acute inflammation infiltration at the TEF 1 week
after modeling (before surgery). (Color version of figure is
available online.)
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nursing can be easily implemented, allowing the animal to
survive after surgery. In addition, the space in the neck is
larger than that in rats, which help completing the operation.
Furthermore, bronchofibroscopy, gastroscopy, and endotra-
cheal intubation can be applied in dogs in a manner similar to
those used in humans. Second, 1 week after establishment of
the model, acute inflammation infiltration (Fig. 6) occurred at
the TEF, followed by fibrosis changing and cicatrization, all of
which are consistent with the clinical characteristic of TEFFig. 5 e Hydroxyproline levels of groups A, B, and C. The
hydroxyproline levels of groups A and C were significantly
different on postoperative days 7, and among three groups
were significantly different on postoperative day 14 and 56
(P< 0.001 for all two-group comparisons at each time
point). Hydroxyproline levels of group A were significantly
increased on day 14 and 56 (day 14 versus day 7, and day 56
versus 14, both P< 0.001) and hydroxyproline levels of
group B (both P< 0.001). The hydroxyproline levels of
group C remained unchanged during the study (P[ 0.978).and surgery repair. We consider this model to be reflective of
the pathologic process.
Therefore, based on the results of our previous study4 and
the present study, the “double-patch” technique has the
following features: (1) there is no need to separate the fistula;
(2) the part of the esophagus with the defect could be used to
repair the fistula and the tracheal defect could be repaired
with an esophagus segment itself without mucosa; (3) the
esophageal segment adhering to the fistula should be tighter;
(4) a pedicled muscle flap is not needed in this technique as
the tracheal wall is reinforced with two patches to resist
airway pressure; (5) reconstruction of the digestive conduit is
needed; (6) the operation is easy and low risk; and (7) there is a
low risk of recurrence.
This is the first study to use an animal model to show that
the “double-patch” technique is more effective when
esophageal patches without mucosa are used, and this is a
novel technique for the treatment of acquired nonmalignant
complicated TEF and BGSF. This study has several limitations,
such as very short duration of observation; relatively small
sample size; and the observation indices consisting primarily
of gross specimens, hydroxyproline levels, and HE staining.
Further studies should use molecular biology, immunohisto-
chemistry, and electron microscopy techniques to assess the
changes in the esophageal patches in greater detail.Conclusions
In conclusion, the “double-patch” technique without mucosa
has potential for use as a safe, easy, and effective method to
repair acquired nonmalignant complicated TEF and BGSF.Acknowledgment
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